Haemodynamic effects of riociguat in inoperable/recurrent chronic thromboembolic pulmonary hypertension

Date
2017
Author
Hoeper, Marius M.
Gruenig, Ekkehard
Jansa, Pavel
Fritsch, Arno
Wang, Chen
Torbicki, Adam
Simonneau, Gerald
Neurohr, Claus
Mayer, Eckhard
Davie, Neil
Ghofrani, Hossein-Ardeschir
Kim, Nick H.
D'Armini, Andrea M.
Grimminger, Friedrich
Metadata
Show full item record
Abstract
Objective We compared the haemodynamic effects of riociguat in patients with inoperable chronic thromboembolic pulmonary hypertension (CTEPH) or persistent/recurrent CTEPH after pulmonary endarterectomy in the Chronic Thromboembolic Pulmonary Hypertension Soluble Guanylate CyclaseStimulator Trial 1 study.
URI
http://hdl.handle.net/20.500.12627/179225
https://doi.org/10.1136/heartjnl-2016-309621
Collections